Rankings
▼
Calendar
PTCT Q4 2016 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PTCT
PTC Therapeutics, Inc.
$5B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$25M
Gross Profit
-$20,000
-0.1% margin
Operating Income
-$25M
-99.2% margin
Net Income
-$27M
-106.4% margin
EPS (Diluted)
$-0.78
QoQ Revenue Growth
+9.6%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$15M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$269M
Total Liabilities
$150M
Stockholders' Equity
$120M
Cash & Equivalents
$232M
← FY 2016
All Quarters
Q1 2017 →
